The bad news
By 2040, the MASLD prevalence rate for adults is projected to increase to more than 55%
GLP-1 medications generally aren't appropriate with: Personal/family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia type 2 (MEN 2) History of pancreatitis Severe gastroparesis or GI motility disorders Pregnancy, trying to conceive, or breastfeeding A history of eating disorders (requires careful evaluation) Josh reviews your full history at your consult to confirm treatment is safe for you
BPC 157 has a finalized Nexus Lab Verified record that reports 99.65% HPLC area-percent purity for the represented batch
01 Jun 5 Signs Youre a Good Candidate for GLP-1 Weight Loss Medication Medically reviewed by Elyssa Blissenbach, MD Board Certified, American Boards of Internal Medicine & Obesity Medicine Licensed to practice in FL, GA, SC, AL, VA, NC NPI #1881601714 Last reviewed: 2026-06-12 GLP-1 medications like semaglutide and tirzepatide have changed whats possible for medical weight loss, but they are not the right tool for everyone
